Nektar Therapeutics | NKTR - Equity Capital And Reserves


Nektar Therapeutics reported $576.22M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agios Pharmaceuticals USD 1.03B 83.09M Jun/2026
ALKERMES USD 1.81B 57.02M Jun/2026
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Amgen USD 11.69B 2.5B Jun/2026
Baxter International USD 6.21B 163M Jun/2026
BioCryst Pharmaceuticals USD -454.29M 99.55M Jun/2026
Biogen USD 18.85B 196.3M Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Cara Therapeutics USD 14.5M 6.44M Mar/2026
Cipla INR 344.32B 15.13B Mar/2026
Dr.Reddys Laboratories INR 386.74B 7.82B Jun/2026
Eisai JPY 906.56B 7.57B Jun/2026
Eli Lilly USD 33.88B 2.68B Jun/2026
Exelixis USD 1.84B 91.99M Jun/2026
Gilead Sciences USD 11.74B 11.77B Jun/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Grifols EUR 6.21B 133.12M Dec/2025
Halozyme Therapeutics USD 143.54M 76.09M Jun/2026
Incyte USD 6.34B 721.58M Jun/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
Ironwood Pharmaceuticals USD -217.14M 44.69M Mar/2026
Karyopharm Therapeutics USD -265.65M 27.28M Mar/2026
MacroGenics USD 42.87M 21.68M Jun/2026
Merck USD 41.93B 3.94B Jun/2026
Nektar Therapeutics USD 576.22M 486.38M Mar/2026
Neurocrine Biosciences USD 3.69B 286.2M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sarepta Therapeutics USD 1.53B 22.7M Jun/2026
Takeda JPY 7.56T 215.7B Jun/2026
Teva Pharmaceutical Industries USD 7.75B 475M Jun/2026
Xencor USD 503.23M 12.4M Jun/2026